BACE1 and Alzheimer disease: Moreover, miRNAs can directly modulate APP transcripts, the alternative splicing of APP, BACE1 transcripts, and related kinases to control amyloidogenic APP processing, exerting regulatory effects on Aβ pathologies in AD.